Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy
Tomography · 17.12.2025 · 11 (12) · 143
DOI: 10.3390/tomography11120143 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Tomography, online erschienen am 17.12.2025. Verfasst von Neda Nilforoushan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cancer-associated fibroblasts (CAFs) are an abundant and diverse cell population within tumor microenvironments of solid tumors. Multiple subtypes of CAFs, defined by molecular and functional markers, have been described in the literature. CAFs contribute to tumor progression by remodeling the extracellular matrix, promoting immune evasion, and supporting angiogenesis and metastasis. Fibroblast activation protein (FAP) is a transmembrane serine protease minimally expressed in normal adult tissues but significantly upregulated in certain subtypes of CAFs across many solid tumors. High levels of FAP have been associated with poor prognosis in various cancers. FAP has increasingly emerged as a promising target for both imaging and therapy. Multiple FAP-targeting strategies, such as small molecules, monoclonal antibodies, drug conjugates, and radiolabeled ligands, are currently being investigated in preclinical and early clinical settings. This review provides a clinically focused overview of CAFs in the tumor microenvironment, highlighting key fibroblast markers, their associations with prognosis across various tumor types, and their utility in radiologic imaging and targeted therapy. We also discuss the potential of non-FAP fibroblast targeting molecules and the clinical rationale for more selective, subtype-specific strategies. By examining fibroblast biology through a radiologist’s lens, we aim to explore the evolving role of stromal targeting in imaging and the treatment of solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Faculty of Medicine, University of Freiburg, 79110 Freiburg, Baden Wurttemberg, Germany.
- Department of Pathology, Fox Chase Cancer Center, Temple University, Philadelphia, PA 19111, USA.
- Department of Radiology, University of Wisconsin-Madison, Madison, WI 53792, USA.
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
ORCID-Profile: Maierdan Palihati, Yashvi Patel, Anna O Giarratana
Förderung
- NCI NIH HHS
Zitieren
APA
Nilforoushan, N., Khavaran, A., Palihati, M., Patel, Y., Giarratana, A. O., Das, J. P., & Capaccione, K. M. (2025). Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy. Tomography, 11(12), 143. https://doi.org/10.3390/tomography11120143
Vancouver
Nilforoushan N, Khavaran A, Palihati M, Patel Y, Giarratana AO, Das JP, et al. Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy. Tomography. 2025;11(12):143. doi:10.3390/tomography11120143
BibTeX
@article{Nilforoushan2025,
author = {Nilforoushan, Neda and Khavaran, Ashkan and Palihati, Maierdan and Patel, Yashvi and Giarratana, Anna O and Das, Jeeban Paul and Capaccione, Kathleen M},
title = {Cancer-Associated Fibroblasts: Clinical Applications in Imaging and Therapy},
journal = {Tomography},
year = {2025},
volume = {11},
number = {12},
pages = {143},
doi = {10.3390/tomography11120143}
}
EUVIMED